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This work presents a first approach to the design, development, and implementation of a smart device for the real-time
measurement and detection of alterations in heart rate variability (HRV). The smart device follows a modular design scheme,
which consists of an electrocardiogram (ECG) signal acquisition module, a processing module and a wireless communications
module. From five-minute ECG signals, the processing module algorithms perform a spectral estimation of the HRV. The
experimental results demonstrate the viability of the smart device and the proposed processing algorithms.
1. Introduction
Cardiovascular diseases are among the main causes of
population death [1]. It is estimated that 17.3 million people
worldwide die as a result of cardiovascular disease, which
represents 30% of all cases [2]. High blood pressure, smoking
habits, diabetes, visceral obesity, dyslipidemia, physical inac-
tivity, and unhealthy eating patterns are the main modifiable
risk factors associated with the development of cardiovascu-
lar diseases [2]. Cardiac autonomic dysfunction is a risk
factor that is also related to the development of cardiovascu-
lar diseases and can be noninvasively measured through
heart rate variability (HRV) assessment [3].
HRV refers to the continuous heart rate or continuous
RR wave intervals extracted from electrocardiogram (ECG)
signal [4] (time distance between the R waves in the ECG
signal is denoted as RR intervals). Short- and long-term
variations in heart rate (HR) can be due to different causes.
The parasympathetic nervous system causes that HR, and
in turn, blood pressure (BP) decreases, while the sympathetic
nervous system favors an antagonistic action, increasing both
HR and BP. The interaction of these systems is known as the
sympathetic-vagal balance of the autonomic nervous system
(ANS) [5]. Many studies have shown that HRV is a useful
quantitative indicator to assess the balance between the
cardiac sympathetic nervous system and the parasympathetic
nervous system and can be used in the diagnosis and preven-
tion of some cardiovascular diseases such as congestive heart
failure, sudden cardiac death, arrhythmia, or Holmes-Adie
syndrome [4, 6–9].
In the last decades, an attempt has been made to analyze
and quantify HRV so that it can serve as a clinical utility.
Measurements of HRV are made over long- and short-term
periods. Long-term recordings typically last 24 hours and
are carried out by means of a Holter, while short-term
recordings last 2–5 minutes and are usually performed with
a dynamic ECG [10].
The analysis of HRV is of interest in other multiple
conditions, such as respiratory diseases. This analysis can
be used as a simple and noninvasive method for the estima-
tion of aerobic capacity in subjects with COPD [11], and it
can also be used as a prognostic tool, since in these patients,
a reduced HRV has been related to an increase in morbidity
and mortality [12]. In addition, respiratory muscle strength
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has been related to the sympathetic-vagal response, which
can be evaluated by HRV [13]. Other applications of HRV
range from the early biomarker for the evaluation of diabetes
mellitus progress [14], and diagnostic marker in chronic neck
pain [15], to mental and physical health [16], or sleep quality
[17], and work stress [18], among others.
Methods for the measurement of HRV can be classified
into temporal and frequency domain methods. The first ones
consist mainly of a statistical analysis of RR intervals. How-
ever, their capabilities are limited, as they do not show
sufficient specificity and sensitivity, in addition to the need
of long recording periods [10].
The methods in the frequency domain or spectral
estimation of HRV can be classified into parametric and
nonparametric methods. Nonparametric methods based on
the fast Fourier transform (FFT) have as main advantage
their simplicity and algorithmic speed [10], while parametric
methods, such as autoregressive (AR) models, provide a
more defined, smooth, and easy-to-identify spectral compo-
nent [10]. In addition, for short-duration measurements,
parametric methods provide better spectral resolution than
nonparametric methods [10].
To the knowledge of the authors, there are no devices that
allow real-time analysis of HRV through the aforementioned
methods. Some adapted methods have been proposed for the
real-time analysis [19], such as the short-time Fourier trans-
form (STFT), wavelet transform, Hilbert-Huang transform,
and from infinite impulse response (IIR) filters [20], but
always executed off-line with ECG signals from previously
acquired records.
The present work shows a first approach to the design of
a portable, customizable, and low-cost smart device for the
real-time measurement of HRV in the frequency domain
through AR models.
2. Materials and Methods
In the context of the present work, smart device is referred to
as a device that not only has sensing capabilities for the
measurement of certain variables, but is also equipped with
a wireless communications unit and has the capability of
carrying out a process of the acquired information. The
design, development, and evaluation processes of the device
have been performed in an iterative (or spiraling) methodol-
ogy, testing the developments before and more often than in
the traditional cascaded life cycle. In the design and simula-
tion stage, Orcad software (version 16.0) of Cadence has been
used. For the implementation of the prototypes CircuitCam
(version 5.2) and BoardMaster (version 5.0), programs have
been used, as well as a ProtoMat S62 milling machine, all
of LPKF.
A first evaluation of the device performance was made by
considering its most representative characteristics, compar-
ing them with other devices and systems recently proposed
in the literature. The gain and the bandwidth were calculated
from the simulation of the electronic design using the Tina-
TI software of Texas Instruments. The power consumption
was estimated using the procedure described in [21]. For that
purpose, a resistor of 10 ohms was placed in series in the line
that feeds the Front-End stage from the battery. With an
oscilloscope (MSO6032A of Agilent Technologies), the volt-
age at the resistor was measured to approximate, according
to Ohm’s law, the input current to the circuit. This current,
constant over time, was multiplied by the supply voltage of
3.3V to obtain the power consumption.
The interest of the present device is its capability to
compute the HRV parameters in the frequency domain in
real time. For this process, it is common to make an estima-
tion of the power spectral density (PSD) of the HRV signal.
As shown in Figure 1, very low frequency (VLF) spectral
components are obtained in the range 0.0033–0.04Hz [22],
low frequency (LF) spectral components in the range of
0.04–0.15Hz, and high frequency (HF) spectral components
in the range of 0.15–0.4Hz [19]. These components provide
clinical information about the variation in the sinus rhythm
of the heart. LF components reflect both sympathetic and
parasympathetic influences, although LF may be indicative
of baroreflex sensitivity [23]. HF components are related to
the parasympathetic system; thus, the LF/HF ratio is indica-
tive of sympathovagal balance [23].
The power spectral components are quantified by mea-
suring the area under the three frequency bands: VLF power,
LF power, and HF power. The spectral components of HRV
should be presented in the natural base; hence, a logarithmic
transformation could be necessary. In order to ease the com-
parison among different studies, the components are usually
presented in normalized units, according to the following
expressions [24]:
LFnu =
PLF
PT − PVLF
⋅ 100,
HFnu =
PHF
PT − PVLF
⋅ 100,
1
where PLF and PHF represent the power of either LF or HF
components, respectively, LFnu and HFnu are indicative of
the corresponding powers in normalized units (percentage),
PT represents total power (equivalent to variance computed
with time domain approaches), and PVLF indicates the power
of the VLF component. LF/HF ratio is calculated as the ratio
of LFnu and HFnu.
For the validation of the sensor and the algorithms
used, two sets of experiments were carried out. The subjects
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Figure 1: Example of the signal PSD obtained by the smart device.
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breathed spontaneously but were not allowed to talk.
Informed consent was obtained from all subjects.
In the first set of experiments, two ECG signal acquisition
experiments with a duration of 5 minutes were performed on
a 23-year-old male volunteer weighing 90 kg, having an
apparent healthy condition and under different situations.
In the experiments, the volunteer remained motionless,
without speaking and avoiding any kind of biofeedback. For
the first experiment (sitting experiment), the subject was
asked to sit in a chair in a comfortable and relaxed manner
with the eyes closed. The second experiment (stimuli experi-
ment) was performed under the same conditions as the first
experiment, but in this case, the volunteer was subjected to
random auditory stimuli with the purpose of analyzing the
influence of external disturbances on the ANS. Each of the
experiments was in turn repeated on two separate occasions.
In the second set of experiments, a standardized pro-
tocol for the study of HRV was used [25], to allow a
comparative analysis of the system against results obtained
in the previous studies [23, 26–28]. The study involved 5
volunteers, of apparent healthy condition. Table 1 shows a
detail of the anthropometric characteristics of the volun-
teers. Measurements were performed in the morning. Each
subject performed two experiments, each with a duration
of five minutes:
(i) Rest experiment: the volunteer remains immobile in
a supine position.
(ii) Tilt experiment: the volunteer remains immobile in a
standing position.
3. Design Results
3.1. Smart Device Design. Figure 2 shows the design of the
smart device following a modular scheme comprising the
following elements:
(i) Sensing module: its function is to provide an electro-
chemical interface between the tissue and the elec-
tronic measurement subsystem (front-end module)
for voltage detection. This interface is performed
through the electrode-skin contact, consisting of
a metal electrode, an electrolytic gel (usually con-
taining Cl−), and human skin. For such purpose,
three diagnostic DORMO-TAB electrodes (Ag-AgCl
pregelled flexible electrodes with dimensions of
26.4mm× 22.5mm) were placed on the test users,
the first located under the clavicle on the right shoul-
der, the second under the collarbone on the left
shoulder, and the third on the abdomen on the lower
left side. These electrodes were connected to the
front-end module via cables.
(ii) Front-end module: it is the acquisition element of
the monitored signal. It consists of an ECG signal
capture system based on an instrumentation ampli-
fier (INA), a feedback circuit through the third
electrode, three filter stages, and an amplification
step, all implemented through operational amplifiers.
(iii) Processing module: it is responsible for the process-
ing of the ECG signal and the frequency analysis for
the spectral estimation of the HRV. An OLIMEX
PIC32-PINGÜINO-OTG module has been used
for data processing, which can be sent wirelessly in
real time. The OLIMEX module makes use of a
PIC32MX440F256H microcontroller, with 256KB
of program memory, 32KB of data memory, and a
maximum speed of 80MHz.
(iv) Communication module: it is responsible for the
bidirectional wireless communications of the smart
device: the transmission of the result of the signal
processing to an external unit (a computer in this
first prototype) in one sense, and the reception of
configuration commands for the personalization of
the processing algorithms in the other. In this case,
an RN42-I/RM module from microchip has been
used to implement communications based on the
Bluetooth standard.
3.2. Design of the Front-End Module. The front-end input
stage consists of an INA composed by three operational
amplifiers with an approximate gain of 33 dB. The input dif-
ferential impedance is bootstrapped to increase the input
resistance and increase the quality of the signal-to-noise ratio
[29, 30]. Through a voltage follower, the INA common mode
is obtained, which is inverted and amplified so that it is
subsequently feedbacked through the right leg to obtain an
increase of the common-mode rejection ratio (CMRR),
reducing the impact of interferences in the output signal [31].
A high-pass filter with a cutoff frequency of 0.5Hz is then
implemented. This filtering is performed from a low-pass
filter, with the same cutoff frequency, which feedbacks the
continuous level of the INA output signal as its reference
voltage. This configuration allows a higher gain in the ampli-
fier avoiding the saturation in the subsequent stages due to a
high DC level.
Next, two-unit gain filtering steps are included. The
interference of the electrical installation is attenuated by a
notch filter adjusted to the frequency of 50Hz. Then, a
low-pass filter is configured with a cutoff frequency of
150Hz to minimize the effects of other possible sources
of noise, usually at a high frequency.
Table 1: Characteristics of the experiments performed in the
second set of experiments (mean value± standard deviation).
Number of volunteers 5
Men/women 3/2
Age (years) 26.4± 4.9
Weight (kg) 73.6± 11.1
Height (cm) 174.6± 8.2
Body mass index 24.1± 1.7
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Finally, an inverter amplifier with an approximate gain
of 30 dB is used as the last gain stage to provide a measur-
able signal to the analog-to-digital converter (ADC) of the
processing module.
The ADC was implemented taking advantage of one
of the available peripherals of the PIC32MX440F256H
microcontroller, which is the core of the OLIMEX PIC32-
PINGÜINO-OTG module. This device allows up to 16-
channel 10-bit ADC, with a maximum sampling rate of
1000 ksps. Although it was shown that a sampling rate as
low as 50Hz could be used to measure the ECG signal
without compromising the accuracy of the calculated time
domain HRV parameters [32], other studies recommend
the frequency of 200Hz to avoid possible distortions in the
frequency spectrum of the signal [33], the basis of the
analysis shown in the present work. For this reason, a
sampling frequency of 200Hz was selected as the working
frequency of the device, to minimize computational load
and energy consumption, while ensuring a quality in the
results after processing.
For the front-end design, surface mount resistors and
capacitors of standard size 0603 and surface mount opera-
tional amplifiers of the Texas Instruments OPA211 series
have been used. The OPA211 was chosen because it has a
main characteristic, a very low input noise (80nVpp), and is
ideal for medical applications.
3.3. Processing Module. The estimation of HRV in the
frequency domain from the ECG signal is obtained by a
five-step algorithm:
(i) In a first step, the signal S0 corresponding to the
output signal of the ECG front-end is elevated
to the third power. In this way, the signal S1
is obtained, allowing a better definition of the
QRS complex.
(ii) In the second stage, from the second derivative of
S1, a new signal S2 is generated corresponding to
the following expressions:
Figure 2: Proposed modular design scheme.
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S2a n = S1 n + 1 − S1 n ,
S2 n = S2a n + 1 − S2a n 2,
2
where n represents the current sample. This process-
ing allows the easy detection of the R wave.
(iii) In the third stage, the signal S3 is obtained as the
estimation of the RR intervals, expressed in seconds.
A register of the last maximum values of the R-wave
in the signal S2 is saved, eliminating the older values
to dynamically adapt to changes in the amplitude of
the signal.
From this register, the detection threshold Thd is
defined as 30% of the maximum value of all of
them. This threshold allows limiting the search
interval of the R-wave. The instant at which the
wave is maximum in the search interval is set as
the R-instant. A new value is then defined in the
RR interval vector as the difference between the
current R-instant and the previous one.
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Figure 3: Signals obtained in one of the experiments: (a) fragment of the output signal of the ECG front-end (S0); (b) signal S1; (c) signal S2;
(d) RR intervals of the complete signal (S3).
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Figure 4: Spectral estimation of the HRV of the experimental
signal for some of the analyzed orders of the AR model by the
Burg method.
Figure 5: Prototype of the smart device for the measurement
of HRV.
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(iv) In the fourth stage, the spectral estimation of S3
using AR models is obtained by the Burg method
of order N, where N is a configurable parameter
[34]. As the signal acquisition time is small, the use
of the Burg method is an appropriate option, since
it has the advantage of a higher resolution and stabil-
ity for a small amount of data [35]. The algorithm
was implemented by following the recommenda-
tions described in [36] to improve the frequency
estimation.
(v) Finally, in the fifth stage, LFnu, HFnu, and LF/HF
parameters were calculated according to the equa-
tions and procedures described in the Materials
and Methods section.
4. Validation Results
As a sample of the signals with which the processing module
operates, Figure 3 shows the result of the first three stages of
the algorithm described in the previous section for a sitting
experiment. Figure 3(a) shows a 20-second segment of S0
output signal from the ECG front-end. Figure 3(b) shows
the signal S1 as a result of raising the S0 signal to the third
power to increase the definition of the QRS complex of the
ECG signal. Figure 3(c) shows the signal S2, which allows
the easy detection of the R wave. Finally, Figure 3(d) shows
the complete signal S3 as the result of the estimation of the
RR intervals of the S2 signal. This last signal represents a time
signal distributed along the horizontal axis, also of a temporal
nature, which will be the basis of the subsequent analysis in
the frequency domain.
Given the interest represented by the calculation of the
power spectral density for the analysis of the HRV signal,
the Burg parameter N in the fourth stage of the algorithm
was optimized. To select the order of the filter, different
values were tested from N = 10 to N = 32, which is the
recommended range for this type of applications [34],
increasing their value in steps of two.
Figure 4 shows the results obtained for some of the
analyzed values of the parameter N. The value that allowed
a correct spectral estimation was considered as optimum.
The smaller the N the smoother the signal, making it difficult
to detect the spectral components, while the higher the N
the higher the number of peaks generated in the frequency
spectrum, thus making it difficult to analyze and requiring
in this case a longer computational time. After this analysis,
N = 16 was established as the optimal value of the parameter,
since it was the minor order that offered an adequate defini-
tion of the spectral components.
The implementation of the smart device prototype is
shown in Figure 5.
The spectral analysis of the first set of experiments
(sitting experiment and stimuli experiment) was applied in
a first validation of the device and its processing algorithm.
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Figure 6: Example of the spectral estimation of the first set of experiments: (a) sitting experiment and (b) stimuli experiment.
Figure 7: Example of the spectral estimation of HRV (female
volunteer) in the second set of experiments.
Figure 8: Example of the spectral estimation of HRV (male
volunteer) in the second set of experiments.
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This evaluation was done in this case in a qualitative way,
analyzing the spectrum of the signals by inspection. Figure 6
shows a comparison of the spectral estimation of two of the
experiments performed, in which the spectral components
LF and HF are identified.
In the sitting experiment, in which the user was relaxed, it
can be seen that the HF component is dominant over the LF
component. This outcome is in agreement with the expected
result, since in this case, there should be a greater activity of
the parasympathetic system above the sympathetic, as it
corresponds to a state of rest and relaxed. In the stimuli
experiment, the volunteer was subject to different distur-
bances. In this case, the LF component was dominant, which
also agrees with the expected results.
The results obtained encouraged a more detailed study
using the standardized protocol described in Materials and
Methods section and the second set of experiments (rest
experiments and tilt experiments). As an example, Figures 7
and 8 show the HRV spectral estimation of a female volun-
teer and a male volunteer, respectively. Each of the figures
also represents the PSD of the two experiments performed
by each volunteer: rest and tilt experiments. In both graphs,
an increase in the LF component and a decrease in the HF
component are observed when going from the supine posi-
tion to the standing position. In the case shown in Figure 7,
there is even an inversion in the position of the maximum
of the spectral components, located in HF during the rest
experiment and in LF during the tilt experiment.
To define more precisely the relation between the spectral
components when comparing the two cases (rest and tilt), a
quantitative analysis was also performed using normalized
parameters of the HRV spectral characteristics described
above: LFnu, HFnu, and LF/HF.
The use of standardized parameters and a standard
protocol favors the comparison with other results in the
literature. Table 2 shows the results obtained in this study
and a sample of equivalent data obtained by other authors
for healthy subjects.
Table 2: Comparison of the results obtained with the prototype in the second set of experiments with respect to other studies (mean, standard
deviation (SD), maximum (M), and minimum of LFnu, HFnu, and LF/HF).
This work [27] [28] [37] [38] [23] [39]
LFnu (%)
Rest
Mean 42.7 71 56 61 74.6
SD 13.6 6 17 14.5
Maximum 54.8 73
Minimum 16.4 48
Tilt
Mean 78.3 85 83 69 76.4
SD 11.8 4.5 12 14.4
Maximum 93.5 80
Minimum 63.1 56
HFnu (%)
Rest
Mean 53.3 29 44 39 26.3
SD 14 6 17 10.9
Maximum 80.1 52
Minimum 43.7 27
Tilt
Mean 19.7 15 17 31 20.3
SD 11.2 4.8 12 10.1
Maximum 36.2 44
Minimum 6.1 20
LF
HF
Rest
Mean 0.89 2.47 1.7 1.5 3.4 1.69 1.15
SD 0.36 1.01 1.4 1.6 0.42 0.3
Maximum 1.23 2.16
Minimum 0.2 0.9
Tilt
Mean 6.64 5.56 8.4 2.1 5.3 10.4 4
Mean 5.16 2.48 6.9 3.8 1.82 1
Maximum 15.32 4.1
Minimum 1.74 1.3
Table 3: Thresholds and classification rules depending on the value
of LFnu, HFnu, and LF/HF.
LFnu
<58.94% Rest experiment
≥58.94% Tilt experiment
HFnu
<39.93% Tilt experiment
≥39.93% Rest experiment
LF
HF
<1.49 Rest experiment
≥1.49 Tilt experiment
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Data of Table 2 show results comparable to those
found in other studies, both in absolute and relative
values. In addition, the same trend and the same relation-
ships between the parameters are observed. LFnu is higher
in tilt experiments than in the rest experiments. The
reverse is true for HFnu. The LF/HF ratio has a value close
to unity in the rest experiments, but is much higher for
tilt experiments.
It can also be seen from Table 2 that the maximum
and minimum values of the different parameters do not
overlap. In this sense, a threshold can then be set for each
of the parameters that could be employed in a hypotheti-
cal recognition and classification of the experiments. For
LFnu, the average value between the maximum value of
the parameter in the rest experiments and the minimum
value of the parameter in the tilt experiments is set as
the classification threshold. The same procedure is used
to calculate the threshold of the LF/HF parameter. In
contrast, the threshold of the parameter HFnu is calculated
as the average value between the minimum value in the
rest experiments and the maximum value in the tilt exper-
iments. Table 3 shows the classification rules according to
the previous thresholds.
Figure 9 graphically displays the distribution of the
parameters around the classification thresholds, marked with
a solid line. The graphs also show the confidence interval of
68.27% (±standard deviation) obtained for each parameter
in each of the experiments. These intervals are marked with
dash lines and serve to highlight the statistical distribution
of the results.
Regarding the device performance, Table 4 summarizes
some features of the device and compared to a few recent
works. The main advantage of the device compared to other
commercial and literature proposals is its capacity for the
real-time detection of alterations in heart rate variability
(HRV) through frequency analysis. To the knowledge of the
authors, this capacity is not implemented in portable devices,
being the offline analysis from the data stored in memory the
most common method [45].
In the first set of experiments, corresponding to the
functional evaluation of the front-end, the ECG data
captured by the device were wirelessly sent in real time to a
computer, acting as the processing module, where they were
analyzed with Matlab software (version 2016a). Each sample
was sent sequentially by the Bluetooth communication
module, used as a serial port, with a transmission rate of
200 samples per second (two bytes per sample).
After these positive results, in the second set of experi-
ments, the algorithm was embedded in the physical process-
ing module of the prototype. Table 5 shows some details of
the implementation of the algorithm in the sensor prototype.
The second set of experiments was conducted using the
device in stand-alone mode according to which the device
carried out the following tasks:
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Figure 9: Results of parameters in the second set of experiments: (a) LFnu, (b) HFnu, and (c) LF/HF.
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(i) Sequential wireless transmission of ECG samples for
its registration and subsequent evaluation.
(ii) On-line S3 calculation as the estimation of the RR
intervals. This process, executed within the device,
requires a time of 193μs to run, enough to be exe-
cuted in real time whenever a new sample is
received at 200Hz, without interfering with the
next sample.
(iii) Every five minutes, estimation of HRV in the fre-
quency domain from the RR intervals. This process,
also executed within the device, requires a time of
409.2ms to run, enough for a real-time application.
(iv) Calculation of LFnu, HFnu, and LF/HF from the
PSD of the HRV signal and wireless transmission
of the result.
The algorithm was also executed simultaneously on a
computer with the ECG samples sent by the device. The
coincidence in the results obtained by the device with respect
to the computer demonstrates the viability of the prototype
for the execution of the proposed algorithm in real time.
5. Conclusions
In the present work, a first approximation to a smart device
and a processing algorithm for the spectral analysis of HRV
in real time has been shown. To the best of our knowledge,
this capability is not available in any portable ECG mea-
surement device. Under the requirements of low-cost, cus-
tomizable, and low power consumption, the hardware and
software required for ECG signal capture and its subse-
quent processing have been designed and implemented.
A qualitative validation was performed in two different
experiments, repeated twice each. In a first experiment, in
which the volunteer was relaxed, the observed spectral com-
ponents indicated a greater activity of the parasympathetic
system above the sympathetic one. In a second experiment,
in which the volunteer was subjected to external stimuli,
the spectral components showed a greater activity of the
sympathetic system above the parasympathetic one. The
results obtained in this first approximation show the via-
bility of the device and the algorithms proposed for a
real-time qualitative analysis of the ANS and the influence
of different perturbations.
For a more exhaustive evaluation, a second set of experi-
ments was performed. Standard parameters were used in the
spectral analysis of the HRV as well as a standardized
measurement protocol (rest and tilt experiments). A compar-
ative analysis with respect to the results obtained in other
studies has shown the validity of both the device and the
proposed algorithms for the quantitative evaluation of the
HRV spectral components. In addition, a method has been
established for the classification of rest and tilt activities from
an ECG signal.
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